International Clinical Trial: A Prospective, Phase II, Single-Arm Study on the Efficacy and Safety of Neoadjuvant Short-Course Radiotherapy Combined with Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer

Geneva, Feb. 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119083) titled 'A Prospective, Phase II, Single-Arm Study on the Efficacy and Safety of Neoadjuvant Short-Course Radiotherapy Combined with Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer' on Feb. 14.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Beijing Friendship Hospital, Capital Medical University

Condition: Rectal cancer

Intervention: Treatment group:? Radiotherapy: Total dose of 25 Gy delivered in 5 fractions, 5 Gy per fraction, over a total course of 5 days (Target area: Only the gross rectal tumor and radiologically suspected metastatic positive lymph nodes, wi...